Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats

Bone

Volumn 41, Issue 4, 2007, Pages 639-645

  Wezeman, Frederick H ^a   Juknelis, Dainius ^a   Himes, Ryan ^a   Callaci, John J ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Alcohol; Bone; Ibandronate; Osteoporosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALCOHOL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; IBANDRONIC ACID; PARATHYROID HORMONE; VITAMIN D;

ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE REMODELING; BONE STRENGTH; BONE TURNOVER; CANCELLOUS BONE; COMPRESSIVE STRENGTH; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; MALE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; QUANTITATIVE ANALYSIS; RAT; SINGLE DRUG DOSE;

ALCOHOLS; ANIMALS; BONE DENSITY; BONE RESORPTION; CALCIUM; COLLAGEN TYPE I; DIPHOSPHONATES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SPINE; STRESS, MECHANICAL; VITAMIN D;

EID: 34548522991     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.06.002     Document Type: Article

References (40)

1. Wechsler H., and Nelson T.F. Binge drinking and the American college student: what's five drinks?. Psychol. Addict. Behav. 15 (2001) 287-291
2. Callaci J.J., Juknelis D., Patwardhan A.G., Sartori M., Frost N., and Wezeman F.H. The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate hormone treatment. Alcohol., Clin. Exp. Res. 28 (2004) 182-191
3. Wezeman F.H., Emanuele M., Moskal S.F., Steiner J., and LaPaglia N. Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat. J. Bone Miner. Res. 15 (2000) 2033-2041
4. Callaci J.J., Juknelis D., Patwardhan A.G., and Wezeman F.H. Binge alcohol treatment increases vertebral bone loss following ovariectomy: compensation by intermittent parathyroid hormone. Alcohol., Clin. Exp. Res. 30 (2006) 1-8
5. Wezeman F.H., Emanuele M.A., Emanuele N., Moskal S.F., Woods M., Suri M., et al. Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength. Alcohol., Clin. Exp. Res. 23 (1999) 1534-1542
6. Heaney R.P., and Weaver C.M. Calcium and vitamin D. Endocrinol. Metab. Clin. N. Am. 32 (2003) 181-194
7. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., and Vieth R. Estimates of optimal vitamin D status. Osteoporos. Int. 16 (2005) 713-716
8. Heaney R.P. Advances in therapy for osteoporosis. Clin. Med. Res. 1 (2003) 93-99
9. Heaney R.P. The vitamin D requirement in health and disease. J. Steroid Biochem. Mol. Biol. 97 (2005) 13-19
10. Erben R.G., Mosekilde L., Jesper T.S., Weber K., Stahr K., Leyshon A., et al. Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1α,25-dihydroxyvitamin D3. J. Bone Miner. Res. 17 (2002) 1498-1511
11. Erben R.G., Bromm S., and Stangassinger M. Therapeutic efficacy of 1α,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1α,25 dihydroxyvitamin D3 on bone. Endocrinology 139 (1998) 4319-4328
12. Erben R.G., Scutt A.M., Miao D., Kollenkirchen U., and Haberey M. Short-term treatment of rats with high dose 1,25-dihydroxyvitaminD3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow. Endocrinology 11 (1997) 4629-4635
13. Heaney R.P. The vitamin D requirement in health and disease. Steroid Biochem. Mol. Biol. 97 (2005) 13-19
14. Li M., Mosekilde L., Sogaard C.H., Thomsen J.S., and Wronski T.J. Parathyroid hormone monotherapy and co-therapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats. Bone 16 (1995) 629-635
15. 3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Ostoporos. Int. 13 (2002) 257-264
16. Bischoff-Ferrari H.A., Dawson-Hughes B., Willett W.C., Staehelin H.B., Bazemare M.G., Zee R.Y., et al. Effect of vitamin D on falls: a meta analysis. J. Am. Med. Assoc. 291 (2004) 1999-2006
17. Cranney A., Guyatt G., Griffith L., Wells G., Tugwell P., and Rosen C. The Osteoporosis Methodology Group, the Osteoporosis Research Advisory Group. IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr. Rev. 23 (2006) 570-578
18. Rogers M.J. New insights into the molecular mechanisms of action of bisphosphonates. Curr. Pharm. Des. 9 (2003) 2643-2658
19. Barrett J., Worth E., Bauss F., and Epstein S. Ibandronate: a clinical pharmacological and pharmacokinetic update. J. Clin. Pharm. 44 (2005) 951-965
20. Monier-Faugere M., Geng Z., Paschalis E., Qi Q., Arnala I., Bauss F., et al. Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral properties. J. Bone Miner. Res. 14 (1999) 1768-1778
21. Bauss F., Wagner M., and Hothorn L.H. Total administered dose of ibandronate determines its effects on bone mass and architecture in ovariectomized aged rats. J. Rhuematol. 29 (2002) 990-998
22. Chesnut C.H., Skag A., Christiansen C., Recker R., Stakkestad J.A., Hoiseth A., et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J. Bone Miner. Res. 19 (2004) 1241-1249
23. Nation J.R., Burkey R.T., and Grover C.A. Lead/ethanol interactions and pharmacokinetics. Alcohol 10 (1993) 363-367
24. Steinke B., Patwardhan A.G., Havey R., and King D. Human growth hormone transgene expression increases the biomechanical structural properties of mouse vertebrae. Spine 24 (1999) 1-4
25. Penland S., Hoplight B., Obernier J., and Crews F.T. Effects of nicotine on ethanol dependence and brain damage. Alcohol 24 (2001) 45-54
26. Turner R.T. Skeletal response to alcohol. Alcohol., Clin. Exp. Res. 24 (2000) 1693-1701
27. Chakkalakal D.A. Alcohol-induced bone loss and deficient repair. Alcohol., Clin. Exp. Res. 29 (2005) 2077-2090
28. Sampson H.W. Effect of alcohol consumption on adult and aged bone: a histomorphometric study of the rat animal model. Alcohol., Clin. Exp. Res. 22 (1998) 2029-2034
29. Peng T.C., Kusy R.P., Hirsch P.F., and Hagman J.R. Ethanol induced changes in morphology and strength of femurs of rats. Alcohol., Clin. Exp. Res. 12 (1988) 1655-1659
30. Sampson H.W. Effect of alcohol consumption on adult and aged bone: a histomorphometric study of the rat animal model. Alcohol., Clin. Exp. Res. 22 (1998) 2029-2034
31. Hogan H.A., Groves J.A., and Sampson H.W. Long-term alcohol consumption in the rat affects femur cross-sectional geometry and bone tissue material properties. Alcohol., Clin. Exp. Res. 23 (1999) 1825-1833
32. Wezeman F.H., Juknelis D., Frost N., and Callaci H.J. Spine bone mineral density and vertebral body height are altered by alcohol consumption in growing male and female rats. Spine 31 (2003) 87-92
33. Ammann P., and Rizzoli R. Bone strength and its determinants. Osteoporos. Int. 14 Suppl. 3 (2003) S13-S18
34. Rockoff S.D., Sweet E., and Bluestein J. The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae. Calcif. Tissue Res. 3 (1969) 163-175
35. Ito M., Nishida A., Koga A., Ikeda S., Shiraishi A., Uetani M., et al. Contribution of trabecular and cortical components to the mechanical properties of bone and their regulating parameters. Bone 31 (2002) 351-358
36. Price P.A., Faus S.A., and Williamson M.K. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 817-824
37. Erben R.G., Weiser H., Sinowatz F., Rambeck W.A., and Zucker H. Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats. Calcif. Tissue Int. 50 (1992) 228-236
38. Lange J.E., Clapp J.D., Turrisi R., Reavy R., Jaccard J., Johnson M.B., et al. College binge drinking: What is it? Who does it?. Alcohol., Clin. Exp. Res. 26 (2002) 723-730
39. Okoro C.A., Brewer R.D., Naimi T.S., Moriarty D.G., Giles W.H., and Mokdad A.H. Binge drinking and health-related quality of life: do popular perceptions match reality?. Am. J. Prev. Med. 26 (2004) 230-233
40. Faden V.B., and Fay M.P. Trends in drinking among Americans age 18 and younger: 1975-2002. Alcohol., Clin. Exp. Res. 28 (2004) 1388-1395